Daniel Geschwind, MD, PhD
Gordon and Virginia MacDonald Distinguished Professor of Human Genetics, Neurology and Psychiatry
at the David Geffen School of Medicine
Senior Associate Dean & Associate Vice Chancellor of Precision Health, Institute for Precision Health,
University of California, Los Angeles
Dr. Daniel H. Geschwind is the Gordon and Virginia MacDonald Distinguished Professor of Neurology, Psychiatry and Human Genetics at UCLA. In his capacity as Senior Associate Dean and Associate Vice Chancellor of Precision Health, he leads the Institute for Precision Health (IPH) at UCLA. In his laboratory, his group has pioneered the application of systems biology methods in neurologic and psychiatric disease, with a focus on autism spectrum disorders (ASD) and neurodegenerative conditions. His laboratory has made major contributions to identifying genetic causes of autism spectrum disorder, defining the molecular pathology of autism and allied psychiatric disorders, and has worked to increase diversity in autism research.
Dr. Geschwind sits on editorial boards of Cell, Science and Neuron, and is among the highest cited neurologists in the world. He has received several awards for his laboratory’s work including the American Neurological Association (ANA) Derek Denny-Brown Neurological Scholar Award, most recently the Society of Biological Psychiatry Gold Medal Award and the American Academy of Neurology’s 2022 Cotzias Lecture and Award. He is the 2022 National Academy of Medicine recipient of the Rhoda and Bernard Sarnat International Prize in Mental Health, the highest such award in this area by the National Academies. He is an elected Member of the American Association of Physicians and the National Academy of Medicine.